PEPTONIC medical AB (publ) (XSAT:PMED)
Sweden · Delayed Price · Currency is SEK 0.0600
0.00 (0.00%)
At close: Jan 31, 2024
PEPTONIC medical AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.63 | 0.2 | 3.74 | 15.13 | 3.57 | 10.15 |
Cash & Short-Term Investments | 0.63 | 0.2 | 3.74 | 15.13 | 3.57 | 10.15 |
Cash Growth | -90.49% | -94.79% | -75.29% | 324.40% | -64.88% | -74.17% |
Accounts Receivable | - | - | - | - | - | 5.17 |
Other Receivables | 3.96 | 7.82 | 3.76 | 9.28 | 12.42 | 2.54 |
Total Trade Receivables | 3.96 | 7.82 | 3.76 | 9.28 | 12.42 | 7.71 |
Inventory | 5.26 | 5.62 | 4.99 | 16 | 15.37 | 10.32 |
Total Current Assets | 9.85 | 13.64 | 12.49 | 40.42 | 31.35 | 28.19 |
Net Property, Plant & Equipment | 0.29 | 0.31 | 0.4 | 3.78 | 4.3 | 4.2 |
Other Intangible Assets | 50.62 | 51.96 | 57.57 | 62.54 | 50.1 | 104.42 |
Total Assets | 60.76 | 65.92 | 70.46 | 106.74 | 85.75 | 84.6 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 2.44 | 4.36 | 3.25 | 7.56 | 4.18 | 6.22 |
Accrued Expenses | 1.3 | 5.28 | 1.37 | 4.5 | 5.88 | 7.03 |
Short-Term Debt | 4.48 | 9.43 | 12.58 | 13.78 | 22.88 | 15.35 |
Other Current Liabilities | 3.37 | 8.6 | 4.71 | 5.58 | 5.72 | 2.89 |
Total Current Liabilities | 11.59 | 27.67 | 21.91 | 31.41 | 38.66 | 31.48 |
Total Liabilities | 11.59 | 27.67 | 21.91 | 31.41 | 38.66 | 31.48 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 2.07 | 42.95 | 40.32 | 38.37 | 24.27 | 19.16 |
Additional Paid-in Capital | 431.43 | 373.86 | 363.62 | 333.04 | 273.61 | 248.44 |
Accumulated Other Comprehensive Income | 0.23 | 0 | 0.44 | 5.38 | 7.39 | 9.62 |
Retained Earnings | -384.56 | -378.57 | -355.82 | -301.47 | -258.19 | -224.1 |
Shareholders' Equity | 49.18 | 38.24 | 48.55 | 75.32 | 47.09 | 53.12 |
Total Liabilities & Equity | 60.76 | 65.92 | 70.46 | 106.74 | 85.75 | 84.6 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 4.48 | 9.43 | 12.58 | 13.78 | 22.88 | 15.35 |
Net Cash (Debt) | -3.86 | -9.23 | -8.84 | 1.36 | -19.32 | -5.19 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | - | -0.00 | -0.00 | 0.00 | -0.08 | -0.03 |
Book Value | 49.18 | 38.24 | 48.55 | 75.32 | 47.09 | 53.12 |
Book Value Per Share | 0.01 | 0.01 | 0.01 | 0.06 | 0.19 | 0.28 |
Tangible Book Value | -1.45 | -13.72 | -9.02 | 12.79 | -3.01 | -51.3 |
Tangible Book Value Per Share | -0.00 | -0.00 | -0.00 | 0.01 | -0.01 | -0.27 |